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Life-threatening Reactions to 
Propofol 
To the Editor: Propofol (2,6-diisopro-
pyl phenol; Diprivan; Stuart Pharmaceu-
ticals, Wilmington, DE) has been advo-
cated as a titratable continuous infusion 
anesthetic agent associated with fast and 
smooth recovery (2, 7). The anesthetic 
properties of a smooth induction, short 
half-life, and rapid emergence from an-
esthesia after prolonged operations, with 
a low incidence of nausea and vomiting 
and little Nhangover* sedation, suggest 
that this agent may be ideally suited for 
use in intracranial neurosurgery (6). It 
also may be given in combination with 
analgesics, such as sufentanyl and inha-
lational agents. Accordingly, we have 
adopted propofol for use in all cranial 
base, vascular, and functional neurosur-
gical procedures. We are currently using 
propofol (50-100 ~g/kg/min infusion, 
with a burst suppression dosage of ap-
proximately 250 ~g/kg/min used during 
periods of vascular interruption) in a bal-
anced protocol with narcotic (sufentanyl) 
and low dosage inhalational (isoflurane) 
anesthesia. 
We have experienced two potentially 
life-threatening complications among 
our flrst 150 patients undergoing propo-
fol anesthesia at our institution. Both fe-
male patients (ages 28 and 39) received 
the balanced protocol (one receiving 
burst-suppressive dosages of propofol). 
Both patients experienced a rapidly 
evolving postoperative submandibular 
and laryngeal swelling with airway com-
promise, one requiring intubation and 
the other requiring an emergent trache-
ostomy for airway control within hours 
of emergence from anesthesia. Com-
puted tomographic scans of the neck in 
both cases demonstrated massive swell-
ing of laryngeal and facial soft tissue, 
consistent with angioneurotic edema. 
This pronounced swelling subsided 
slowly over a 4-day period with no per-
manent sequelae. The Cl esterase inhibi-
tor (Cl INH) level on one patient tested 
revealed no abnormality. Of note is that 
both of these patients had previously re-
ceived general anesthesia for unrelated 
surgical procedures without complica-
tion. 
In an initial cooperative, comparative 
study of the use of propofol in 1465 pa-
: 10 
tients undergoing a variety of surgical 
procedures, the agent compared favor-
ably with other common infusional 
agents, such as thiopentone and metho-
hexitone, in side effects produced (7). Re-
cently, however, several reports of ana-
phylactoid reactions to this agent have 
emerged (1, 3-5). Propofol is insoluble in 
water and necessitates administration in 
emulsion form. Initially, the potential 
risk of such reactions with the surfactant 
carrier "Cremaphor ELH (2) prompted a 
substitution with a fatty emulsion con-
taining soybean oil, glycerol, and egg 
phosphatide. The replacement of the 
Cremaphor carrier has clearly not elimi-
nated the risk (3, 4). The higher incidence 
of severe allergic reactions to the drug in 
our experience may merely represent 
sampling error. It could also be suggested 
that the large total doses administered 
during extended cranial base and vascu-
lar procedures may increase the risk of 
such an occurrence; careful postopera-
tive monitoring is essential to provide 
safe airway control in the event of such 
a reaction. 
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